Login / Signup

Polymyxin B-induced Bartter syndrome.

Bhavesh Mohan LalNimisha Musthafa HafeesaNaval Kishore VikramAnimesh Ray
Published in: BMJ case reports (2024)
Bartter syndrome is a genetic disorder characterised by chloride-unresponsive metabolic alkalosis, hypokalaemia, hypomagnesaemia and hypercalciuria. While it commonly presents antenatally or in early infancy, sometimes, drugs can induce a state similar to Bartter syndrome in any age group, called acquired Bartter syndrome. Polymyxins and aminoglycosides are the most commonly implicated drugs. Polymyxin B and polymyxin E (popularly known as colistin) are the two chemically similar polymyxins that are commonly used clinically. While colistin is frequently associated with nephrotoxicity, polymyxin B is generally considered less nephrotoxic. This difference is due to the way these two drugs are handled by the kidneys. In this case report, we discuss a middle-aged male who developed Bartter syndrome due to polymyxin B, which resolved on discontinuation of the drug, and re-appeared after its re-introduction later. This case exemplifies the nephrotoxicity caused by polymyxin B and the need for vigilance when using this drug.
Keyphrases
  • case report
  • gram negative
  • drug induced
  • multidrug resistant
  • escherichia coli
  • middle aged
  • drug resistant
  • gene expression
  • genome wide
  • oxidative stress
  • diabetic rats